Diving Into Diabetes

The world of diabetes management is constantly evolving, with new research, new treatments, and new recommendations for best practice. Diving into Diabetes is a series of in-depth conversations with experts who are on the front lines of diabetes research and management. We're starting the conversation with those who are committed to improving and individualizing diabetes treatment to help provide important information and insight for fellow healthcare professionals keen to target the needs of their patients. This podcast is intended for healthcare professionals only. Speaker disclosures are available in each episode’s notes. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the views or positions of any entities they represent. Some information contained herein may cite the use of an unapproved product in a dosage, for an indication, or in a manner other than recommended. Before prescribing any product, always refer to the latest Product Monograph. Financial support for the Diving Into Diabetes program was provided by Sanofi Canada.

MAT-CA-2200968

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(28)

Recent Evidence for Fixed-Ratio Combinations of Basal Insulin and GLP-1 RA vs. Basal-Bolus Insulin in T2D: Updates from ADA 2022

Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonist (GLP-1 RA) have demonstrated maintenance of HbA1c efficacy, less hypoglycemia, and weight loss compared to basal-...

1 Loka 202214min

Practical Tips to Interpreting Continuous Glucose Monitoring Metrics

With newer technologies being used to monitor blood glucose levels, how can we use data from continuous glucose monitoring (CGM) to inform the day-to-day management of diabetes?Our host, Dr. Ronald Go...

1 Loka 202221min

Glucose Variability Results from the InRange Study

Metrics beyond HbA1c such as glucose variability are emerging as key parameters that can help guide the daily management of diabetes, but what is the clinical relevance of such measures, particularly ...

8 Syys 202213min

Prime Time for InRange: Comparison of Insulin Glargine 300 U/mL vs. Degludec 100 U/mL in Type 1 Diabetes

Continuous glucose monitoring (CGM) metrics are emerging as key parameters that can help guide the management of diabetes, but how can they be applied in clinical practice, particularly for those with...

8 Syys 202216min